Changing healthcare practice for older adults with late-stage non-small cell lung cancer: practical considerations of targeted therapy in primary care and oncology.

Journal of the American Geriatrics Society
Tanyanika Phillips ToweNathan A Berger

Abstract

Healthcare practice for cancer care is rapidly evolving because of advances in technology, scientific discovery, drug development, and aging demographics in America. Among the substantive changes in science and drug development is targeted therapy. Targeted agents are changing the scope of practice in treating lung cancer-the leading cause of cancer death in older adults. Given the growing use of these agents in cancer management, shared awareness of practical management considerations between specialists and primary care providers is important. This article reviews targeted therapy in late-stage non-small cell lung cancer (NSCLC) and shared care concerns in continuity of care of older Americans with this disease. Important practice points for providers caring for older patients with late-stage lung cancer treated with targeted therapy are presented through an educational guide addressing potential management concerns.

References

Feb 1, 1993·Annals of Internal Medicine·M C Creditor
May 16, 2000·Chest·C C EarleJ C Weeks
Sep 27, 2000·The Journal of ECT·A J de Carle, R Kohn
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Jan 8, 2003·International Journal of Cancer. Journal International Du Cancer·C Martin TammemagiPaul Kvale
Mar 6, 2003·Journal of the National Cancer Institute·Paul A Bunn, Rogerio Lilenbaum
Dec 22, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott D RamseyBonnie Donato
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John R JohnsonRichard Pazdur
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea BezjakUNKNOWN National Cancer Institute of Canada Clinical Trials Group Study BR.21
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Paul J HeskethDavid R Gandara
Jul 17, 2007·Lancet·Louise MalletAllen Huang
Dec 12, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C-P KuoY-T Lu
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suresh S RamalingamUNKNOWN Eastern Cooperative Oncology Group
Mar 21, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·P S HallJ E Brown
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul Wheatley-PriceFrances A Shepherd
Jul 25, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kathleen LangDavid Thompson
Jul 25, 2008·Clinical Lung Cancer·Muthu Veeraputhiran, Mark Sundermeyer
Jul 26, 2008·Nature Nanotechnology·Ben L Feringa, Wesley R Browne
Aug 5, 2008·Clinical Obstetrics and Gynecology·Kevin A Ault
Mar 6, 2009·The Annals of Pharmacotherapy·Sarah M Gressett, Sachin R Shah

❮ Previous
Next ❯

Citations

Jan 1, 2011·Journal of Community Hospital Internal Medicine Perspectives·Sabarish AyyappanTimothy J Woodlock

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.